Lenalidomide-associated hypothyroidism.
Menon
Smitha
S
Habermann
Thomas
T
Witzig
Thomas
T
D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced*; D000077269:Lenalidomide; D016393:Lymphoma, B-Cell / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008875:Middle Aged; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide